Quality of Life Assessment in Patients Undergoing Prolonged Suppressive Antibiotherapy for Prosthetic Joint Infection. (PSA-QOL)
Sponsor: Groupe Hospitalier Diaconesses Croix Saint-Simon
Listed as NCT02805803, this NA trial focuses on Prosthetic Joint Infection and remains ongoing. Sponsored by Groupe Hospitalier Diaconesses Croix Saint-Simon, it has been updated 10 times since 2016, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
10 versions recorded-
Nov 2025 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Nov 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Oct 2023 — Jul 2024 [monthly]
Recruiting NA
-
Apr 2022 — Oct 2023 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Jan 2021 — Apr 2022 [monthly]
Recruiting NA
-
Jun 2018 — Jan 2021 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
-
Feb 2017 — Mar 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting NA
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Groupe Hospitalier Diaconesses Croix Saint-Simon
For direct contact, visit the study record on ClinicalTrials.gov .